Sale!

EFHC1 Gene Epilepsy juvenile absence type 1 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The EFHC1 gene plays a crucial role in the development of epilepsy, specifically juvenile absence epilepsy type 1 (JAE1). This condition is characterized by sudden, brief lapses in consciousness, often accompanied by subtle body movements. These episodes, known as absence seizures, typically begin in childhood or adolescence.

The genetic test for identifying mutations in the EFHC1 gene associated with JAE1 is a critical tool for diagnosis and management of the condition. Conducted at DNA Labs UAE, this test involves analyzing the patient’s DNA to detect any abnormalities in the EFHC1 gene that may contribute to the development of epilepsy.

Understanding the genetic basis of JAE1 through this test can provide valuable insights into the most effective treatment plans, helping to manage or reduce the frequency of seizures. Additionally, it can offer important information for family planning purposes for those with a family history of epilepsy.

The cost of the EFHC1 gene epilepsy juvenile absence type 1 genetic test at DNA Labs UAE is 4400 AED. This investment in health can be a crucial step towards a more informed and personalized approach to managing juvenile absence epilepsy.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

EFHC1 Gene Epilepsy Juvenile Absence Type 1 Genetic Test

Welcome to DNA Labs UAE, a leading genetic lab offering the EFHC1 Gene Epilepsy Juvenile Absence Type 1 Genetic Test. This test helps in the diagnosis and management of juvenile absence epilepsy, a condition characterized by sudden, brief periods of loss of consciousness.

Test Components

The EFHC1 Gene Epilepsy Juvenile Absence Type 1 Genetic Test includes the following components:

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the EFHC1 Gene Epilepsy Juvenile Absence Type 1 Genetic Test, it is important to provide the following information:

  • Clinical History of Patient who is going for EFHC1 Gene Epilepsy, juvenile absence type 1 NGS Genetic DNA Test
  • A Genetic Counselling session to draw a pedigree chart of family members affected with EFHC1 Gene Epilepsy, juvenile absence type 1

Test Details

The EFHC1 gene is associated with juvenile absence epilepsy. Through NGS genetic testing, we can identify mutations or variations in the EFHC1 gene that may be responsible for this condition. This information is valuable for the diagnosis and management of juvenile absence epilepsy.

If you suspect that you or a family member may have juvenile absence epilepsy, we recommend considering the EFHC1 Gene Epilepsy Juvenile Absence Type 1 Genetic Test. Our experienced neurologists and genetics experts are here to assist you throughout the testing process.

Test Name EFHC1 Gene Epilepsy juvenile absence type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for EFHC1 Gene Epilepsy, juvenile absence type 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with EFHC1 Gene Epilepsy, juvenile absence type 1
Test Details

The EFHC1 gene is associated with juvenile absence epilepsy, a type of epilepsy characterized by sudden, brief periods of loss of consciousness. NGS genetic testing can identify mutations or variations in the EFHC1 gene that may be responsible for this condition. This information can help in the diagnosis and management of juvenile absence epilepsy.